The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday:** Dublin-based Shire Plc, whose proposed sale to AbbVie Inc fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals Inc , Bloomberg reported, citing people familiar with the matter.
AbbVie Inc. (AbbVie) is a global research-based pharmaceuticals company. Shares of ABBV traded higher by 2.02% or $1.32/share to $66.57. In the past year, the shares have traded as low as $45.50 and as high as $70.76. On average, 12539700 shares of ABBV exchange hands on a given day and today's volume is recorded at 5300799.
NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide. Shares of NPSP traded higher by 18.44% or $5.62/share to $36.09. In the past year, the shares have traded as low as $22.11 and as high as $39.68. On average, 1611830 shares of NPSP exchange hands on a given day and today's volume is recorded at 5560632.
Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shares of SHPG traded higher by 3.12% or $6.51/share to $215.27. In the past year, the shares have traded as low as $136.29 and as high as $264.98. On average, 1964190 shares of SHPG exchange hands on a given day and today's volume is recorded at 1225388.
Source
